Page last updated: 2024-11-01

niclosamide and Small Cell Lung Carcinoma

niclosamide has been researched along with Small Cell Lung Carcinoma in 2 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Small Cell Lung Carcinoma: A form of highly malignant lung cancer that is composed of small ovoid cells (SMALL CELL CARCINOMA).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Hochmair, M1
Rath, B1
Klameth, L1
Ulsperger, E1
Weinlinger, C1
Fazekas, A1
Plangger, A1
Zeillinger, R1
Hamilton, G1
He, X1
Li, M1
Ye, W1
Zhou, W1

Other Studies

2 other studies available for niclosamide and Small Cell Lung Carcinoma

ArticleYear
Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines.
    Investigational new drugs, 2020, Volume: 38, Issue:4

    Topics: Antigens, CD; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Humans; Lung Neop

2020
Discovery of degradable niclosamide derivatives able to specially inhibit small cell lung cancer (SCLC).
    Bioorganic chemistry, 2021, Volume: 107

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Evaluation, Preclinical; Drug

2021
chemdatabank.com